HIGHLIGHTS
SUMMARY
When analyzing the antibiotic resistance profiles before and after the onset of the COVID-19 pandemic, the authors found similar resistance rates, the only significant differences being in the case of gentamicin, with a decreased resistance, from 82.6% to 52.5% (p=0.001), and in the case of ceftazidime + avibactam (CAZ-AVI), which presented a higher resistance, from 53.8% to 75.8% (p=0.049). The authors observed that out of the 87 strains, 72 (82.7%) were carbapenemase-producing, as follows: 26 (36.1%) OXA-48-producing strains, 25 (34 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.